A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantStefano Sacchi, Luciano Masini, Alberto Fragasso et al.|Leukemia & lymphoma/Leukemia and lymphoma|2011Cited by 28
A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMAStefano Sacchi, Maura Brugiatelli, Raffaella Marcheselli et al.|IRIS UNIMORE (University of Modena and Reggio Emilia)|2009Cited by 1